Noriko Aoki

Learn More
BACKGROUND Osteoporosis is a complication of rheumatoid arthritis (RA). We identified risk factors for osteoporosis during treatment with biologics. METHODS Femoral neck bone mineral density (BMD) was measured in 186 patients with biologics-treated RA. We compared the characteristics of those with BMD ≥70% of young adult mean (YAM) and those with BMD <70%(More)
A male marihuana user with amotivational syndrome who responded poorly to neuroleptic therapy was treated four times with weekly intramuscular injection of caerulein in a dose of 0.6 micrograms/kg. He was maintained on his previous neuroleptic medication during the study period. The BPRS was used to rate the patient's symptoms. There were remarkable(More)
Caerulein, a decapeptide chemically related to CCK-8, was administered intramuscularly to 20 patients with chronic schizophrenia in two different doses of 0.3 and 0.6 microgram/kg. BPRS ratings were made before and 3 weeks after the injection. The neuroleptic therapy was not discontinued, but both drug and dose were not changed at least 3 weeks before the(More)
  • 1